Vidac Pharma to list on Hamburg Stock Exchange
The Israeli clinical stage oncology drug developer has a share subscription facility of up to €20 million from Luxembourg-based GEM.
Source: globes.co.il
📰 Koronis Foundation News
Koronis Foundation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Koronis Foundation. Real-time updates on events, politics, business and more.